Đang hiển thị 1 - 5 kết quả của 5 cho tìm kiếm 'Vibhuti Vyas (15055988)', thời gian truy vấn: 0.01s Tinh chỉnh kết quả
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... Bằng Ibrahim Aldoss (15055961)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... Bằng Ibrahim Aldoss (15055961)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... Bằng Ibrahim Aldoss (15055961)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... Bằng Ibrahim Aldoss (15055961)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... Bằng Ibrahim Aldoss (15055961)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: